Skip to main content
Erschienen in:

23.03.2020 | Original Article

Effects of partial internal biliary diversion on long-term outcomes in patients with progressive familial intrahepatic cholestasis: experience in 44 patients

verfasst von: Hamid Reza Foroutan, Ali Bahador, Sultan Mohsin Ghanim, Seyed Mohsen Dehghani, Mohammad Hossein Anbardar, Mohammad Reza Fattahi, Mehdi Forooghi, Omidreza Azh, Ali Tadayon, Alireza Sherafat, Amir Arsalan Yaghoobi, Mohammad Ali Ashraf

Erschienen in: Pediatric Surgery International | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Progressive familial intrahepatic cholestasis (PFIC) is a hereditary disease characterized by cholestasis, which may cause jaundice, severe pruritus, and cirrhosis in the later stages. By the invention of biliary diversion methods, these patients were prevented from undergoing liver transplant. Using biliary diversion techniques, the entero-hepatic cycle was interrupted. This lowers the bile acid pool and resolves the pruritus. Herein, we report 44 cases of PFIC who underwent partial internal biliary diversion (PIBD) and long-term follow-up of these children. This comprises the largest case series of PIBD.

Methods

All patients were diagnosed by liver biopsy as PFIC before the operation. All underwent cholecysto colic bypass by jejunal interposition due to severe pruritus unresponsive to medication. Laboratory blood tests, sonography, and physical exam were done before and after the operation once every 3 months. Besides, a questionnaire was designed to ask the patients about the symptoms after the operation, and a pruritus score was measured using the 5D-itch scale.

Results

44 children (25 boys, 19 girls), between 1.75 and 27.5 years (at the time of this study) were followed for a median period of 54 months. Age at operation ranged from 2 months to 18 years, with a median of 29 months. Of these children, 14 were lost to follow up. Results showed a significant decrease in pruritus and sleep disturbance after the surgery (p < 0.001). Also, jaundice decreased from 82.1 before to 7.1% following the surgery. 50% of the patients became medication-free at follow-up.

Conclusion

PIBD is a safe procedure which helps non-cirrhotic children preserve their liver function. Therefore, PIBD prevents them from undergoing liver transplant. Effective results were achieved in terms of severe pruritus and jaundice, and children were able to regain their sleep patterns. It also avoided external stoma, which is more convenient from the patient’s point of view.
Literatur
11.
Zurück zum Zitat Bustorff-Silva J, Neto LS, Olímpio H, de Alcantara RV, Matsushima É, De Tommaso AMA, Brandão MÂB, Hessel G (2007) Partial internal biliary diversion through a cholecystojejunocolonic anastomosis—a novel surgical approach for patients with progressive familial intrahepatic cholestasis: a preliminary report. J Pediatr Surg 42(8):1337–1340. https://doi.org/10.1016/j.jpedsurg.2007.03.029 CrossRefPubMed Bustorff-Silva J, Neto LS, Olímpio H, de Alcantara RV, Matsushima É, De Tommaso AMA, Brandão MÂB, Hessel G (2007) Partial internal biliary diversion through a cholecystojejunocolonic anastomosis—a novel surgical approach for patients with progressive familial intrahepatic cholestasis: a preliminary report. J Pediatr Surg 42(8):1337–1340. https://​doi.​org/​10.​1016/​j.​jpedsurg.​2007.​03.​029 CrossRefPubMed
17.
Zurück zum Zitat Kaliciński PJ, Ismail H, Jankowska I, Kamiński A, Pawłowska J, Drewniak T, Markiewicz M, Szymczak M (2003) Surgical treatment of progressive familial intrahepatic cholestasis: comparison of partial external biliary diversion and ileal bypass. Eur J Pediatr Surg 13(05):307–311. https://doi.org/10.1055/s-2003-43570 CrossRefPubMed Kaliciński PJ, Ismail H, Jankowska I, Kamiński A, Pawłowska J, Drewniak T, Markiewicz M, Szymczak M (2003) Surgical treatment of progressive familial intrahepatic cholestasis: comparison of partial external biliary diversion and ileal bypass. Eur J Pediatr Surg 13(05):307–311. https://​doi.​org/​10.​1055/​s-2003-43570 CrossRefPubMed
19.
Zurück zum Zitat Khan I, Qureshi MA, Karim F, Shaukat M (2018) Surgical treatment for intractable pruritus in progressive familial intrahepatic cholestasis. J Pak Med Assoc 68(6):953–955PubMed Khan I, Qureshi MA, Karim F, Shaukat M (2018) Surgical treatment for intractable pruritus in progressive familial intrahepatic cholestasis. J Pak Med Assoc 68(6):953–955PubMed
29.
Zurück zum Zitat Mali VP, Fukuda A, Shigeta T, Uchida H, Hirata Y, Rahayatri TH, Kanazawa H, Sasaki K, de Ville de Goyet J, Kasahara M (2016) Total internal biliary diversion during liver transplantation for type 1 progressive familial intrahepatic cholestasis: a novel approach. Pediatr Transplant 20(7):981–986. https://doi.org/10.1111/petr.12782 CrossRefPubMed Mali VP, Fukuda A, Shigeta T, Uchida H, Hirata Y, Rahayatri TH, Kanazawa H, Sasaki K, de Ville de Goyet J, Kasahara M (2016) Total internal biliary diversion during liver transplantation for type 1 progressive familial intrahepatic cholestasis: a novel approach. Pediatr Transplant 20(7):981–986. https://​doi.​org/​10.​1111/​petr.​12782 CrossRefPubMed
Metadaten
Titel
Effects of partial internal biliary diversion on long-term outcomes in patients with progressive familial intrahepatic cholestasis: experience in 44 patients
verfasst von
Hamid Reza Foroutan
Ali Bahador
Sultan Mohsin Ghanim
Seyed Mohsen Dehghani
Mohammad Hossein Anbardar
Mohammad Reza Fattahi
Mehdi Forooghi
Omidreza Azh
Ali Tadayon
Alireza Sherafat
Amir Arsalan Yaghoobi
Mohammad Ali Ashraf
Publikationsdatum
23.03.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Surgery International / Ausgabe 5/2020
Print ISSN: 0179-0358
Elektronische ISSN: 1437-9813
DOI
https://doi.org/10.1007/s00383-020-04641-z

Neu im Fachgebiet Pädiatrie

Vorsicht mit Glukokortikoiden bei Glomerulopathie

Auch niedrig dosierte Glukokortikoide zur Behandlung einer primären Glomerulopathie lassen offenbar die Infektionsgefahr steigen. In einer US-Studie hing das Risiko vor allem mit der kombinierten Anwendung von Immunsuppressiva zusammen.

Die elektronische Patientenakte kommt: Das sollten Sie jetzt wissen

Am 15. Januar geht die „ePA für alle“ zunächst in den Modellregionen an den Start. Doch schon bald soll sie in allen Praxen zum Einsatz kommen. Was ist jetzt zu tun? Was müssen Sie wissen? Wir geben in einem FAQ Antworten auf 21 Fragen.

Medikamente verändern wohl Nährstoffzusammensetzung der Muttermilch

Einige Medikamente wie selektive Serotonin-Wiederaufnahmehemmer können offenbar die Makronährstoffzusammensetzung der Muttermilch verändern. Das birgt möglicherweise gesundheitliche Risiken für manche gestillte Kinder.

Kann man Gestationsdiabetes mit oralen Antidiabetika behandeln?

Der Wunsch, Frauen mit Gestationsdiabetes eine orale Erstlinientherapie anbieten zu können, bleibt auch vorläufig ein Wunsch: Eine orale Stufentherapie hat sich in einer randomisierten Studie nicht als gleichwertig zu einer Insulintherapie erwiesen. 

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.